Anadolu Medical Center
| トルコ | オーストリア | スペイン | |
| 髄膜腫摘出術 | から $21,900 | から $35,000 | から $30,000 |
| 開頭術 | から $5,650 | から $20,000 | から $25,000 |
| 大腸癌に対する放射線療法 | から $7,000 | から $12,000 | から $10,000 |
| トゥルービーム | から $3,500 | から $18,000 | から $12,000 |
| サイバーナイフ | から $4,750 | から $50,000 | から $30,000 |
エダ・タンルクル博士は、アナドル医療センターにて腫瘍内科および化学療法を専門とし、複雑ながん症例の診療に従事しています。
Solak医師は、ハジェテペ大学癌研究所にて複雑な腫瘍症例を専門とする権威あるフェローシップを修了しました。
Prof. Dr. Ahmet Hilmi Kaya is a professor of neurosurgery at Anadolu Medical Center in Gebze, Turkey. He earned his MD from Istanbul University Cerrahpaşa (English program). He completed his neurosurgery residency there from 1996 to 2003. He became a professor in 2015. He also completed observerships at Maastricht University in 2007 and 2009.
His clinical focus includes functional and stereotactic neurosurgery, including deep brain stimulation (DBS) for Parkinson’s disease and essential tremor. He also treats spinal tumors and spinal stenosis and performs spinal instrumentation. He manages skull base and brain tumors. He performs vascular surgery of the central nervous system.
Achievements include leading a Parkinson’s research project at Ondokuz Mayıs University (BAP, Project No. T.597, 2008). He supervised a neurosurgery thesis in 2008. His awards include third place at the 2nd National Congress of the Society of Neurosurgery in 2006, the Turkish Neurosurgical Society Overseas Scholarship in 2008, and the Aysima Altınok Thesis Award in 2009. Several of his papers ranked at the 22nd and 23rd Turkish Neurosurgical Society Scientific Congresses in 2008 and 2009. He is a member of the Turkish Neurosurgical Society and the Turkish Medical Association.
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.
Surgery is not always required for a meningioma. Doctors often recommend observation for small, slow-growing tumors. Non-invasive alternatives like Gamma Knife or CyberKnife treat tumors in tricky locations. Surgical intervention is usually reserved for large or aggressive Grade 2 and 3 tumors causing symptoms.
Bookimed Expert Insight: Turkish neurosurgery centers like Anadolu Medical Center often offer CyberKnife for cases that other clinics might label inoperable. Over 40% of cases we see are managed without open surgery. This trend favors patients with tumors near delicate optic nerves or the brainstem. CyberKnife often preserves functions better than invasive resection in these sensitive areas.
Patient Consensus: Patients initially worried about brain surgery often find relief after learning about non-invasive options. Many note that simple monitoring is enough for years if the tumor stays stable.
Primary treatment for meningioma in Turkey includes microsurgical resection and precision radiation therapy. Surgeons use neuronavigation and intraoperative MRI for accurate tumor removal. Non-invasive options like Gamma Knife and CyberKnife target inoperable tumors. Many Turkish neurosurgery centers hold JCI accreditation for safety.
Bookimed Expert Insight: Anadolu Medical Center stands out because of its affiliation with Johns Hopkins. This partnership brings US-level oncology protocols to the region. The center offers specialized CyberKnife and Gamma Knife technologies. These systems allow doctors to treat complex cases without traditional open surgery.
Patient Consensus: Patients note it is important to choose clinics offering robotic systems. Many appreciate the detailed pre-surgery maps that help protect speech and movement.
Neurosurgeons in Turkey report success rates exceeding 90% for meningioma removal procedures. Specialized centers maintain a 91% success rate for intracranial neurosurgeries using advanced neuronavigation. Benign tumor control typically reaches 95%. Grade I early-stage cases show long-term remission in 85% of patients.
Bookimed Expert Insight: Success often depends on specific equipment availability rather than just surgeon skill. Centers like Memorial Hospital and Liv Hospital prioritize hybrid operating rooms. These rooms allow for immediate post-operative scans while the patient is still sedated. This technology helps surgeons confirm total tumor resection before finishing the procedure. This approach significantly reduces the need for secondary revision surgeries.
Patient Consensus: Patients often mention feeling reassured by the thoroughness of pre-surgical neurological testing. Many note the high level of personal care from nursing staff during recovery.
Most patients stay in the hospital for 3 to 7 days after meningioma surgery. The total recovery period to return to work usually takes 6 to 12 weeks. Specialized centers in Turkey prioritize early mobilization to improve outcomes and speed up discharge.
Bookimed Expert Insight: Turkish oncology centers often use neuro-navigation and neuromonitoring during meningioma removal. These technologies help preserve healthy brain tissue. Our data shows this precision often reduces ICU stays to just 24 hours. Shorter ICU stays help patients begin physical therapy much faster.
Patient Consensus: Patients emphasize that extreme fatigue is normal during the first month home. Many suggest having a caregiver ready for at least 2 weeks after discharge.
Anadolu Medical Center and Memorial Bahcelievler Hospital are Turkey's top JCI-accredited facilities for meningioma. These centers employ board-certified neurosurgeons who specialize in skull-base tumors. Treatment plans utilize advanced systems like Gamma Knife, CyberKnife, and neuronavigation to ensure high precision.
Bookimed Expert Insight: Our clinic data highlights Dr. Serdar Kahraman at Anadolu Medical Center. He brings 35+ years of experience in complex brain surgeries. Anadolu serves a high volume of international patients each year. This clinical depth ensures safe handling of tumors near the optic nerve. Many clinics offer similar technology but few possess this surgical volume.
Patient Consensus: Patients emphasize that receiving a detailed treatment plan before traveling reduces anxiety. They frequently mention the professionalism of neurosurgery teams and the comfort of modern facilities.
Meningiomas can recur even after successful treatment. Grade 1 tumors show a 50% recurrence over 20 years. Grade 2 and 3 tumors return more frequently. Lifelong follow-up with contrast-enhanced MRI is essential. This monitors the site for any regrowth or new tumor tissue.
Bookimed Expert Insight: Turkish neurosurgery centers often integrate Intraoperative MRI (iMRI) during the initial resection. This technology helps surgeons confirm total removal before closing the skull. Our data shows this precision significantly reduces the need for secondary radiation later. This proactive approach helps keep long-term recurrence rates lower for patients.
Patient Consensus: Patients emphasize the relief of having a clear long-term scanning schedule. They note that staying consistent with follow-up appointments provides peace of mind.